Patent Attorneys

est. 1931

Patent Attorneys

est. 1931

„CREATIVITY GIVES THE COMPETITIVE EDGE”

This is the philosophy of our clients. We live this philosophy in our services. Our partnership is founded on 85 years of firm experience – going back to 1931. We have changed the legal landscape with innovative approaches before the Düsseldorf courts and the Federal Supreme Court (e.g. Olanzapin – Eli Lilly X ZR 89/07) or before the CJEU  (z.B. Iodosulfuron – Bayer Crop Science C-229/09) and we become successful for our clients in seemingly hopeless cases in opposition and prosecution.

Based on the experience of three generations of patent lawyers and the creativity of completely different individuals with completely different background we design strategic patent portfolios, enforce IP vigorously against infringers and defend the rights of our clients excessively. The key to our success is the continued exchange of ideas and – we like to think out-of-the-box.

The many victories for and against international market leaders confirm our concept.

13 patent attorneys, each with its own history, provide a broad technical and scientific as well as legal expertise. Over the many years we have selected highly qualified cooperation partners in Germany and all over the world.

This is the philosophy of our clients. We live this philosophy in our services. Our partnership is founded on 85 years of firm experience – going back to 1931. We have changed the legal landscape with innovative approaches before the Düsseldorf courts and the Federal Supreme Court (e.g. Olanzapin – Eli Lilly X ZR 89/07) or before the CJEU  (z.B. Iodosulfuron – Bayer Crop Science C-229/09) and we become successful for our clients in seemingly hopeless cases in opposition and prosecution.

Based on the experience of three generations of patent lawyers and the creativity of completely different individuals with completely different background we design strategic patent portfolios, enforce IP vigorously against infringers and defend the rights of our clients excessively. The key to our success is the continued exchange of ideas and – we like to think out-of-the-box.

The many victories for and against international market leaders confirm our concept.

13 patent attorneys, each with its own history, provide a broad technical and scientific as well as legal expertise. Over the many years we have selected highly qualified cooperation partners in Germany and all over the world.

2009 - SUCCESS IN HISTORIC OLANZAPINE CASE AT FEDERAL SUPREME COURT

2010 - SUCCESSFUL SPC DEFENCE AT EUROPEAN COURT OF JUSTICE

KSVR SUCCESS IN LANDMARK DECISION FOR BAYER CROP SCIENCE

2011/2012 - SUCCESSFUL DEFENCE OF GEMCITABINE PATENT AT FEDERAL SUPREME COURT

KSVR SUCCESS IN LANDMARK DECISION FOR BAYER CROP SCIENCE

2013 - SUCCESSFUL DEFENSE OF IL1RA PATENT AT SUPREME COURT

2013 - VICTORY IN COFFEE CAPSULE BATTLE FOR ECC Vs NESTLÉ

2014 - CONTRACEPTIVE BATTLE RE YASMIN

SUCCESS FOR BAYER Vs HEXAL AND TEVA 2014

2015 - SPC Battle AMGEN vs TEVA

2016 - FEDERAL SUPREME COURT EQUIVALENCY VICTORY IN ALIMTA/PEMETREXED CASE FOR ELI LILLY

2017 - SUCCESSFUL INJUNCTION BASED ON EQUIVALENCY LAW FOR ELI LILLY vs RATIOPHARM

OLG Munich confirms Preliminary Injunction Infringement Decision based on Doctrine of Equivalence

2018 - SUCCESSFUL ATTACK ON EP ADMINISTRATIVE COUNCIL LEGISLATION

Board of Appeal Decision T1063/18 re Valdity of Administrive Council Act declares Rule 28(2) EPC invalid following KSVR TPO reasoning

2019 - SUCCESSFUL DEFENSE OF WORLD'S BEST SELLING PHARMACEUTICAL HUMIRA

The patent of the pharmaceutical Humira was attacked by multiple parties in opposition procedures at the European Patent Office questioning inter alia validity of the priority claim. New EPO followed a new approach to assessing priority developed by KSVR

2020 - SUCCESSFUL DEFENSE OF FAMOUS ALIMTA/PEMETREXED PATENT AT SUPREME COURT

The Alimta/Pemetrexed patent was defended at the Federal Supreme Court and subsequently enforced against various generic companies based on the doctrine of equivalence.

Top ranked in

Legal500 – JUVE – IAM – CHAMBERS – WIRTSCHAFTWOCHE – FOCUS